LightPath Technologies Receives $9.6 Million Purchase Order for Cooled Infrared Cameras From Existing Defense Customer (PR Newswire)
UF startup LightPath Technologies, Inc., announced that it has secured a $9.6 million purchase order for cooled infrared cameras from an existing defense customer for use in defense and security applications, with deliveries expected throughout calendar year 2026.
LightPath Technologies Acquires Amorphous Materials, Inc. (PR Newswire)
UF startup LightPath Technologies, Inc. announced it has acquired the assets of Amorphous Materials, Inc., which is an industrial manufacturer with complementary Chalcogenide glass melting technologies.
Genezen and Atsena Therapeutics Announce Strategic Commercial Manufacturing Partnership (PR Newswire)
UF startup Atsena Therapeutics and Genezen announced a manufacturing partnership to support the clinical development and future production of Atsena’s gene therapies for inherited retinal diseases.
Atsena Completes Part B Dosing and Advances to Pivotal Part C of LIGHTHOUSE Trial (Atsena Therapeutics)
UF startup Atsena Therapeutics announced that dosing is complete in patients enrolled across all adult and pediatric cohorts in Part B of the Phase I/II/III Lighthouse Trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
LightPath Technologies Receives $4.8 Million Purchase Order for Advanced Infrared Camera Systems (PR Newswire)
UF startup LightPath Technologies announced it has received a $4.8 million purchase order with an existing customer related to the supply of advanced infrared camera systems for public safety applications.
Atsena Therapeutics Announces Dosing Complete for Adults in Part B of the Phase I/II/III LIGHTHOUSE Trial Evaluating ATSN-201 to Treat X-Linked Retinoschisis (Globe Newswire)
UF startup Atsena Therapeutics announced that dosing is complete in adults enrolled in Part B of the LIGHTHOUSE study, the Phase I/II/III clinical trial evaluating subretinal injection of ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
Optym Launches LoadAi, Bringing Real-Time Decision Intelligence to Truckload Dispatching (Cision PR Web)
UF startup Optym announced the launch of LoadAi, an AI-powered operations platform built to help truckload carriers reduce empty miles, optimize dispatch decisions, and scale planner productivity across their networks.
LightPath Technologies Awarded $22.1 Million Follow-On Purchase Order To Supply Advanced Infrared Camera Systems (PR Newswire)
UF startup LightPath Technologies, Inc., announced it has secured $22.1 million in follow-on purchase orders with a leading global technology customer related to the supply of advanced infrared camera systems in CY 2027.
LightPath Technologies Secures $18.2 Million Purchase Order To Supply Advanced Infrared Camera Systems (PR Newswire)
UF startup LightPath Technologies announced it has secured an $18.2 million purchase order with a leading global technology customer related to the supply of advanced infrared camera systems in CY 2026.
NovaBone To Unveil First-of-Its-Kind Bioactive Wedge at AOFAS 2025 Annual Meeting in Savannah (PR Newswire)
UF startup NovaBone, a pioneer in synthetic bone graft technologies, will showcase its Bioactive Pre-contoured Wedge (BPW) at the 2025 American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting.